Table 3.
IASP NeupSIG recommendations for the management of neuropathic pain in adults.31 NMDA, N-methyl-d-aspartate; SSRI, selective serotonin reuptake inhibitor; TCAD, tricyclic antidepressant drugs.
| Recommended | Inconclusive evidence | Weak against | Strong against |
|---|---|---|---|
| TCADs SNRIs Pregabalin Gabapentin Lidocaine patch Capsaicin patch Tramadol Botulin toxin A |
Capsaicin cream Carbamazepine Topical clonidine Lamotrigine NMDA antagonists Oxycarbazepine SSRI antidepressants Tapentadol Topiramate Zonisamide |
Cannabinoids Sodium valproate |
Levetiracetam Mexiletine |